Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

314 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

NCT00516321

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site La Jolla, California, United States
View all 191 locations
View Trial Details
Completed

A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

NCT00800735

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Sacramento, California, United States
  • San Francisco, California, United States
  • Lutherville, Maryland, United States
  • Manhasset, New York, United States
View all 23 locations
View Trial Details
Completed

A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

NCT01853254

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • La Jolla, California, United States
  • Long Beach, California, United States
  • San Diego, California, United States
View all 67 locations
View Trial Details
Completed

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

NCT00623428

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • La Jolla, California, United States
  • Lancaster, California, United States
  • Long Beach, California, United States
View all 101 locations
View Trial Details
Completed

Interferon α 2b Pharmacovigilance Study

NCT01841775

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Hospital Federal de Bonsucesso (Bonsucesso Federal Hospital) Rio de Janeiro, Brazil
  • Hospital Universitário Clementino Fraga Filho (Clementino Fraga Filho University Hospital) Rio de Janeiro, Brazil
View Trial Details

Related conditions